Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 24 of the 27 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.

Acceptance and commitment therapy in a psychiatric day hospital—A longitudinal naturalistic effectiveness trial

Open access
Rutschmann, Ronja, Romanczuk-Seiferth, Nina, Richter, Christoph · 2023 · Frontiers in Psychiatry

Abstract

Objectives: Despite the transdiagnostic approach and the good cross-professional applicability, only few studies have examined the effects of Acceptance and Commitment Therapy (ACT) in a naturalistic clinic setting. This study aims to help closing this gap by investigating the effects of ACT in a psychiatric day hospital during COVID pandemic. It was investigated whether psychopathological symptomology decreased, and quality of life and general functioning improved with the treatment. Additionally, longitudinal effects were tested. Methods: Participants in this follow-up-design were 92 patients (64.1% female) of a psychiatric day hospital. Survey data of clinical symptoms, quality of life and global functioning were assessed at three time points (with admission, discharge, and 3 months after treatment). Differences between time points were tested using two-sided paired samples t-tests. Additionally, the reliability of change index (RCI) was calculated. Results: From pre-treatment to post-treatment, symptomology decreased significantly (d = 0.82–0.99, p < 0.001), and global functioning as well as quality of life increased significantly (d = 0.42–1.19, p < 0.001). The effects remained relatively stable, with no significant change between post-treatment and follow-up. The difference between pre-treatment and follow-up was significant for clinical symptoms, physical and psychological wellbeing, and global quality of life (d = 0.43–0.76, p < 0.007). Conclusion: The significant and sustained improvement in all measures indicates that patients are benefiting from the treatment. Since the trial was neither randomized nor controlled, effects have to be interpreted with caution. Possible influences of the pandemic are discussed. Clinical trial registration: http://www.drks.de/DRKS00029992, identifier DRKS00029992. Copyright © 2023 Rutschmann, Romanczuk-Seiferth and Richter.

Overview

CoChat Summary

## TL;DR

This naturalistic follow-up study in a German psychiatric day hospital found significant improvements after ACT in symptomology, global functioning, and quality of life, with effects that were largely maintained at 3 months. Because the trial was not randomized or controlled and was conducted during COVID-19, the authors caution that the gains cannot be attributed to ACT alone.

## Key findings

  • In the final sample of 92 patients (initially 171 agreed; 64.1% female), symptomology decreased significantly from pre- to post-treatment, with large effects (d = 0.82–0.99, p < 0.001).
  • Global functioning and quality of life increased significantly from pre- to post-treatment, with effect sizes ranging from d = 0.42–1.19 (p < 0.001).
  • Effects were relatively stable at 3-month follow-up, with no significant change between post-treatment and follow-up.
  • From pre-treatment to follow-up, symptomology, physical and psychological wellbeing, and global quality of life remained significantly improved, with d = 0.43–0.76 (p < 0.007).
  • On the reliable change index, 55/84 (65.5%) showed reliable improvement in at least one measure from pre- to post-treatment, and 24/54 (44.4%) showed reliable improvement from pre-treatment to follow-up; 7/84 (8.3%) and 8/54 (14.8%) showed reliable deterioration, respectively.

## Methods

  • Design: Longitudinal naturalistic follow-up study with assessments at admission, discharge, and 3 months after treatment.
  • Sample/data: Psychiatric day hospital patients in Germany; 92 met inclusion criteria (including treatment duration of at least 38 days and admission after 16 March 2020); mean age 41.28 years and mean treatment duration 48.35 days.
  • Analysis: Pre-post and pre-follow-up changes tested with two-sided paired-samples t-tests; effect sizes reported as Cohen’s d; reliability of change assessed using the reliable change index (RCI).

## Limitations

  • The paper states the trial was neither randomized nor controlled, so effects must be interpreted with caution and cannot be clearly attributed to ACT rather than external effects or natural symptom improvement.
  • The study was conducted during the COVID pandemic, and the authors state its influence is unclear; pandemic-related restrictions may have altered wellbeing, therapy dose, and dropout patterns.
  • The authors note relatively high dropout rates; a text-supported limitation evident from the design is that the sample was barely preselected and there were different sample sizes across analyses because of missing data and pair-wise deletion.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2022.1052874

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 Flow of participants throughout the study. t1, pre-treatment assessment; t2, post-treatment assessment; t3, follow-up assessment. *16 March 2020: Beginning of Covid-related restrictions in Germany.
FIGURE 1 Flow of participants throughout the study. t1, pre-treatment assessment; t2, post-treatment assessment; t3, follow-up assessment. *16 March 2020: Beginning of Covid-related restrictions in Germany.CC BY · PubMed Central
FIGURE 2 Comparison of pre-treatment, post-treatment, and follow-up scores in the BDI for each participant. Reliable change index was calculated according to Jacobson and Truax (24).
FIGURE 2 Comparison of pre-treatment, post-treatment, and follow-up scores in the BDI for each participant. Reliable change index was calculated according to Jacobson and Truax (24).CC BY · PubMed Central
FIGURE 3 Comparison of pre-treatment, post-treatment, and follow-up scores in the GSI-scale for each participant. Reliable change index was calculated according to Jacobson and Truax (24).
FIGURE 3 Comparison of pre-treatment, post-treatment, and follow-up scores in the GSI-scale for each participant. Reliable change index was calculated according to Jacobson and Truax (24).CC BY · PubMed Central
FIGURE 4 Comparison of pre-treatment and post-treatment scores in the GAF for each participant. Reliable change index was calculated according to Jacobson and Truax (24).
FIGURE 4 Comparison of pre-treatment and post-treatment scores in the GAF for each participant. Reliable change index was calculated according to Jacobson and Truax (24).CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 10 Not checked · 48 Own results and interpretations

27 more claims

Create a free account to see all 64 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 27
  • It may state two separate claims as one. 14
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 27 references

Research works printed but not linked: 9

  1. Romanczuk-Seiferth, 2021, ACT in Klinik und Tagesklinik: Arbeiten mit der Akzeptanz- und Commitment-Therapie in multiprofessionellen Teams.
  2. Hayes, 2022, ACT Randomized Controlled Trials since 1986.
  3. Wengenroth, 2012, Therapie-Tools Akzeptanz- und Commitmenttherapie: Mit Online-Materialien.
  4. Polk, 2016, The Essential Guide to the Act Matrix: A Step-By-Step Approach to Using the Act Matrix Model in Clinical Practice.
  5. Franke, 2014, Symptom-Checklist-90-Standard: SCL-90-S; Manual.
  6. Beck, 2009, Beck-Depressions-Inventar Revision - Deutsche Bearbeitung von M.Hautzinger/F.Keller/C.Kühner.
  7. Conrad, 2016, WHOQOL-OLD und WHOQOL-BREF - Handbuch für die deutschsprachigen Versionen der WHO-Instrumente zur Erfassung der Lebensqualität im Alter.
  8. Zahra, 2010, RCI Calculator.
  9. 2015, International statistical classification of diseases and related health problems, In ICD-10 (10th revision, Fifth edition, 2016).

Cited by

See all 10

Metadata

Authors
Rutschmann, R., Romanczuk-Seiferth, N., & Richter, C.
Affiliations
Humboldt-Universität zu Berlin (DE)
Corresponding author
Rutschmann, Ronja
Venue
Frontiers in Psychiatry
Published
2023-01-11
Volume
13
Pages
1052874-1052874
ISSN
1664-0640 (ISSN-L)
OpenAlex
W4315498234
Cited by
10
References
27
Citations by year
2026: 2 · 2025: 3 · 2024: 5
FWCI
2.90
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Charité – Universitätsmedizin Berlin
  • Deutsche Forschungsgemeinschaft
Topics
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
acceptance and commitment therapy, psychiatric day hospital, psychiatric symptoms, quality of life, global functioning, transdiagnostic treatment, COVID-19 pandemic, longitudinal follow-up, sustained treatment effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acceptance and commitment therapy in a psychiatric day hospital—A longitudinal naturalistic effectiveness trial. https://app.cochat.ai/papers/10.3389/fpsyt.2022.1052874
The paper
Rutschmann, R., Romanczuk-Seiferth, N., & Richter, C. (2023). Acceptance and commitment therapy in a psychiatric day hospital—A longitudinal naturalistic effectiveness trial. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.1052874

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.